BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10632760)

  • 1. Repeated vas occlusion and non-invasive reversal with styrene maleic anhydride for male contraception in langur monkeys.
    Lohiya NK; Manivannan B; Mishra PK
    Int J Androl; 2000 Feb; 23(1):36-42. PubMed ID: 10632760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation for noninvasive reversal following long-term vas occlusion with styrene maleic anhydride in langur monkeys.
    Lohiya NK; Manivannan B; Mishra PK; Sriram S; Bhande SS; Panneerdoss S
    Contraception; 2005 Mar; 71(3):214-26. PubMed ID: 15722073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravasal contraception with styrene maleic anhydride and its noninvasive reversal in langur monkeys (Presbytis entellus entellus).
    Lohiya NK; Manivannan B; Mishra PK; Pathak N; Balasubramanian SP
    Contraception; 1998 Aug; 58(2):119-28. PubMed ID: 9773267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural changes in the spermatozoa of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride.
    Lohiya NK; Manivannan B; Mishra PK
    Contraception; 1998 Feb; 57(2):125-32. PubMed ID: 9589840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural changes in the vas deferens of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride and after its reversal.
    Manivannan B; Mishra PK; Lohiya NK
    Contraception; 1999 Feb; 59(2):137-44. PubMed ID: 10361629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of spermatogenesis and sperm parameters in langur monkeys following long-term vas occlusion with styrene maleic anhydride.
    Mishra PK; Manivannan B; Pathak N; Sriram S; Bhande SS; Panneerdoss S; Lohiya NK
    J Androl; 2003; 24(4):501-9. PubMed ID: 12826690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal.
    Lohiya NK; Suthar R; Khandelwal A; Goyal S; Ansari AS; Manivannan B
    Int J Androl; 2010 Feb; 33(1):e198-206. PubMed ID: 19811546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative suitability of DMSO and NaHCO3 for reversal of RISUGĀ® induced long-term contraception.
    Ansari AS; Hussain M; Khan SR; Lohiya NK
    Andrology; 2016 Mar; 4(2):306-13. PubMed ID: 26748683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vas deferens, a site of male contraception: an overview.
    Lohiya NK; Manivannan B; Mishra PK; Pathak N
    Asian J Androl; 2001 Jun; 3(2):87-95. PubMed ID: 11404791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraception in male monkeys by intra-vas deferens injection of a pH lowering polymer.
    Guha SK; Ansari S; Anand S; Farooq A; Misro MM; Sharma DN
    Contraception; 1985 Jul; 32(1):109-18. PubMed ID: 4053602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive reversal of intraluminal vas deferens polymer injection-induced azoospermia--technology.
    Guha SK
    Asian J Androl; 1999 Sep; 1(3):131-4. PubMed ID: 11250780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II clinical trial of a vas deferens injectable contraceptive for the male.
    Guha SK; Singh G; Ansari S; Kumar S; Srivastava A; Koul V; Das HC; Malhotra RL; Das SK
    Contraception; 1997 Oct; 56(4):245-50. PubMed ID: 9408706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraception with RISUG
    Ansari AS; Badar A; Balasubramanian K; Lohiya NK
    Asian J Androl; 2017; 19(4):389-395. PubMed ID: 27586026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I clinical trial of an injectable contraceptive for the male.
    Guha SK; Singh G; Anand S; Ansari S; Kumar S; Koul V
    Contraception; 1993 Oct; 48(4):367-75. PubMed ID: 8222664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histology of the rat vas deferens after injection of a non-occlusive chemical contraceptive.
    Verma K; Misro MM; Singh H; Mahajan S; Ray AR; Guha SK
    J Reprod Fertil; 1981 Nov; 63(2):539-42. PubMed ID: 7299756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety evaluation of long-term vas occlusion with styrene maleic anhydride and its non-invasive reversal on accessory reproductive organs in langurs.
    Manivannan B; Bhande SS; Panneerdoss S; Sriram S; Lohiya NK
    Asian J Androl; 2005 Jun; 7(2):195-204. PubMed ID: 15897977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility with sodium bicarbonate of styrene maleic anhydride, an intravasal injectable contraceptive, in male rats.
    Koul V; Srivastav A; Guha SK
    Contraception; 1998 Oct; 58(4):227-31. PubMed ID: 9866004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-controlled injectable occlusion of the vas deferens.
    Guha SK; Anand S; Ansari S; Farooq A; Sharma DN
    Contraception; 1990 Mar; 41(3):323-31. PubMed ID: 2323220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-vas deferens injection of styrene maleic anhydride gel for male contraception: is it safe?
    Singh AK
    J Fam Plann Reprod Health Care; 2002 Oct; 28(4):208-9. PubMed ID: 12419065
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of spermatozoa from the proximal vas deferens of vasectomized men.
    Wen RQ; Li SQ; Wang CX; Wang QH; Li QK; Feng HM; Jiang YJ; Huang JC
    Int J Androl; 1994 Aug; 17(4):181-5. PubMed ID: 7995653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.